Evidence map›Paper›PMID 41416099›Full record

ArticleEFSA journal. European Food Safety Authority2025

Modification of the existing maximum residue levels for acetamiprid in various crops and honey.

European Food Safety Authority (EFSA), Giulia Bellisai, Giovanni Bernasconi, Luis Carrasco Cabrera, Irene Castellan, Monica Del Aguila, Lucien Ferreira, Luna Greco, Renata Leuschner, Andrea Mioč and 9 more

Abstract read
In one paragraph

Article in EFSA journal. European Food Safety Authority, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

European Food Safety Authority (EFSA)
Giulia Bellisai
Giovanni Bernasconi
Luis Carrasco Cabrera
Irene Castellan
Monica Del Aguila
Lucien Ferreira
Luna Greco
Renata Leuschner
Andrea Mioč
Stefanie Nave
Hermine Reich
Silvia Ruocco
Alessia Pia Scarlato
Marta Szot
Anne Theobald
Manuela Tiramani
Alessia Verani
Elena Zioga

Funding

NIEHS NIH HHS 27302C0138
6 · The paper itself

Abstract

In accordance with Article 6 of Regulation (EC) No 396/2005, the applicants Nisso Chemical Europe GmbH and Nufarm Europe GmbH submitted two separate requests to the competent national authorities in the Netherlands and Austria, respectively, to modify the existing maximum residue levels (MRLs) for the active substance acetamiprid. The application assessed by Austria included requests to modify the MRLs for plums, soybeans, parsley, rosemary, basil and edible flowers, as well as honey. The request submitted to the Netherlands concerned modifications to the MRLs for soybeans and barley. The data submitted in support of the requests were found to be sufficient to derive MRL proposals for soybeans, plums, parsley, rosemary, basil and edible flowers, and honey. For barley, a data gap was identified due to the lack of processing studies, which precluded the derivation of an MRL proposal. Adequate analytical methods for enforcement are available to control residues of acetamiprid in the plant matrices under consideration, at a validated limit of quantification (LOQ) of 0.01 mg/kg. Based on the risk assessment results, EFSA concluded that the short-term and long-term intake of residues resulting from the use of acetamiprid according to the reported agricultural practices (with the exception of the Good Agricultural Practice (GAP) for barley, for which an MRL is not recommended in the present output) is unlikely to present a risk to consumer health.

Indexed as

acetamipridconsumer risk assessmenthoneyMRLpesticidevarious crops

Identifiers

PMID41416099
PMCPMC12709657

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.